Medtronic MiniMed Recalled 116,645 Insulin Pumps Over Delivery Risk (2026)
Medtronic MiniMed recalled 116,645 MiniMed 640G insulin pumps worldwide, including the United States. The devices can deliver too much or too little insulin when the pump height changes relative to the infusion site due to gravity-driven pressure shifts. Stop using the pump immediately and contact Medtronic MiniMed or your healthcare provider for guidance.
Quick Facts at a Glance
Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
Medtronic MiniMed insulin pumps are used by people with diabetes to continuously deliver insulin. These devices are part of a medical device ecosystem that combines hardware with monitoring and software to manage blood sugar.
Why This Is Dangerous
The infusion pump can mis-dose insulin when its height relative to the infusion site changes. This is due to gravity-driven pressure changes affecting how insulin is delivered.
Industry Context
This recall is not described as part of a broader industry pattern in the provided data.
Real-World Impact
Patients could experience severe blood sugar events requiring emergency care. The recall emphasizes immediate cessation of use and consultation with a clinician.
Practical Guidance
How to identify if yours is affected
Check model numbers on the device or accompanying materials for MMT-1711, MMT-1712, MMT-1751, or MMT-1752.
Confirm that the unit is a MiniMed infusion pump from the Paradigm, 600 series, or BLE 700 series.
Review the recall notification from Medtronic MiniMed and the FDA page for confirmation.
Where to find product info
Recall details and instructions are available on the FDA enforcement page and Medtronic’s recall communications.
What timeline to expect
Refunds or replacements are typically processed within weeks after verification, depending on the manufacturer's procedures.
If the manufacturer is unresponsive
Document all communications with the manufacturer.
File a formal complaint with consumer protection agencies if needed.
Consider consulting a healthcare provider for interim diabetes management guidance.
How to prevent similar issues
Regularly check for recalls on devices used for critical health management.
Stay enrolled in manufacturer recall notifications and review updated safety alerts.
Ask healthcare providers about safer, current-generation pump options when purchasing.
Documentation advice
Keep copies of recall notices, model numbers, purchase receipts, and all communications with the manufacturer and clinicians.
Product Details
Model numbers: MMT-1711, MMT-1712, MMT-1751, MMT-1752. Sold worldwide; US nationwide distribution. No specific sale dates or price information provided.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
116,645 units recalled worldwide
Models: MMT-1711, MMT-1712, MMT-1751, MMT-1752
Hazard: unintended insulin over-delivery or under-delivery due to pump height relative to infusion
Distribution: Worldwide; US nationwide distribution listed
Remedy: Stop using the device; follow manufacturer recall instructions; contact Medtronic MiniMed
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.